Healthcare Health/Fitness

Pfizer

Pfizer beats sales and profit forecasts, mum on future deals

Pfizer Inc (PFE.N) reported stronger-than-expected quarterly results, helped by growing sales of its cancer drugs and demand for its medicines in emerging markets, but did not signal any acquisition plans following its recent failed efforts to buy rival British drugmaker AstraZeneca Plc (AZN.L).

Read Full Article
Valeant Pharmaceuticals International Inc.

Valeant ready to raise Allergan bid to at least $200/share

Valeant Pharmaceuticals International Inc (VRX.TO) (VRX.N) on Monday said in a letter to Allergan Inc's (AGN.N) board of directors that it was prepared to raise its offer to at least $200 per share but stopped short of doing so.

Read Full Article
Medication

Vernalis PLC Announces CTI Becomes Worldwide Licensee for Tosedostat

Vernalis plc today announces that CTI BioPharma Corp. (CTI), a US corporation publicly listed on NASDAQ, replaces the UK venture capital backed Chroma Therapeutics (Chroma) as worldwide licensee of tosedostat. CTI previously held rights to tosedostat in the Americas under a Licence Agreement with Chroma. Chroma no longer retains any ongoing rights or financial interest in tosedostat.

Read Full Article
Experimental candidate vaccine

Fujifilm says to buy U.S. vaccine maker as Ebola spreads

Japan's Fujifilm Holdings Corp said on Monday it would buy 49 percent of Texas-based Kalon Biotherapeutics LLC, which has expertise in manufacturing vaccines used against pandemic influenza, Ebola and other public-health threats.

Read Full Article
Novartis

Australia's CSL buys Novartis influenza vaccine unit for $275 million

Australia's CSL Ltd (CSL.AX), the world's largest blood products company, said on Monday it had agreed to buy Novartis AG's (NOVN.VX) global influenza vaccine business for $275 million.

Read Full Article
Salesforce

Salesforce to make big push into healthcare industry

Salesforce Inc is betting big on healthcare, hiring key personnel and ramping up investment in hopes of replacing outmoded medical industry infrastructure and carving out a $1 billion annual business.

Read Full Article
Sanofi

Actavis, Sanofi among bidders for Omega Pharma

Generic drugmaker Actavis Plc and France's Sanofi SA are among the suitors for privately held Omega Pharma NV [COUCKO.UL], Bloomberg reported, citing people familiar with the matter.

Read Full Article
Medical devices

Investors eye third quarter medical use from hospitals, insurers

Hospitals and insurers are expected to give their clearest view yet on whether people are having more surgeries and other medical procedures during the next few weeks when they report earnings, according to investors who are closely watching U.S. medical services use.

Read Full Article
Medication

Vernalis Opens US Office and Strengthens US Team With the Appointment of SVP Medical Affairs

Vernalis plc (LSE: VER) today announces it has opened its US office in Berwyn, Pennsylvania and has strengthened its US Executive team with the appointment of Dr Pascal Borderies, as SVP Medical Affairs. A physician by training, Pascal joins Vernalis from Actavis' subsidiary

Read Full Article
Cancer Cells

Vernalis Licenses V2006 to RedoxTherapies Inc for Use in Immuno-Oncology

Vernalis plc today announces that it has licensed worldwide rights in vipadenant (V2006), a small molecule A2A receptor antagonist, to RedoxTherapies Inc (Redox). Vipadenant has the potential to disrupt an immunosuppressive mechanism of tumor protection, generating improved efficacy for immunotherapies of certain cancers when used in combination.

Read Full Article
Herbalife Ltd

Herbalife hires former U.S. regulator to head compliance team

Herbalife Ltd, the marketer of weight-management products, energy drinks and nutrition supplements that has come under investigation by the Federal Trade Commission as well as other agencies, has hired a former FTC official as its chief compliance officer.

Read Full Article
A view of the main spa area of The Palms hotel

Global spa, wellness industry estimated at $3.4 trillion: report

A growing middle class and consumers' evolving attitudes toward health and travel have fueled a global spa and wellness industry worth an estimated $3.4 trillion in 2013, according to a report released on Tuesday.

Read Full Article
Healthcare

UnitedHealth to buy doctor management company MedSynergies

UnitedHealth Group Inc (UNH.N) said on Tuesday it agreed to buy MedSynergies, which manages physician practices, adding about 9,300 doctors to the hospital and health system services that its Optum technology-based business currently serves.

Read Full Article
France

France uses tax to put pressure on hepatitis C drug prices

France will tax drugmakers whose costly hepatitis C drugs threaten to throw off course its healthcare budget, the government has said, heaping pressure on pharmaceutical companies like Gilead Sciences to cut their prices.

Read Full Article
Medtronic Inc

New U.S. tax rules may lead Medtronic to redo inversion deal

U.S. medical device maker Medtronic Inc is likely to try to renegotiate the structure and terms of its $42.9 billion deal to buy Ireland's Covidien Plc in response to new U.S. tax rules, according to people familiar with the situation.

Read Full Article
1 2 3 4 5 6 7 8 9 10  

Subscribe to VCpost newsletter

Sign up for our Deals of the Day newsletter.
We will not spam you!

Real Time Analytics